Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Un médecin qui prend des notes

iCRIN

The 13 iCRIN Clinical Research Infrastructures

Last update: 05/10/2024 Reading time: 1min

The objective of the iCRIN is to develop interactions and sharing of expertise between the stakeholders of the Department of Medical-University (DMU) of Neurosciences of the Pitié-Salpêtrière Hospital and the research teams of the Brain Institute. The projects were evaluated by the Scientific Advisory Board of Paris Brain Institute on the expertise, performance, quality and visibility of the structure. 13 projects have been selected and officially started in 2019, backed by the Clinical Investigation Centre of Paris Brain Institute.

By placing the patient at the heart of its concerns, Paris Brain Institute pursues one objective: to develop innovative therapeutic solutions that revolutionize the treatment of neurological and psychiatric diseases.

Bringing basic and clinical research together to maximize the chance of a discovery being translated into treatment is therefore paramount and integral to the Institute’s model. It is from this clear perspective that the unique iCRIN model was created. The objective of these structures is to develop shared expertise between the caregivers of Pitié-Salpêtrière Hospital and the research teams of Paris Brain Institute.

Stroke, Alzheimer’s and Parkinson’s diseases, neurogenetics, neuro-oncology… Organized around 13 key themes exploring all fields of the fight against brain diseases, iCRIN is an accelerator of success for the many clinical research projects of the care services of the ecosystem of Paris Brain Institute.
 

Alzheimer's Disease

Alzheimer's Disease

In collaboration with the Institute for Memory and Alzheimer’s Disease (IM2A), this project aims to: identify new cognitive markers and group specific populations of patients with Alzheimer’s disease; develop clinical applications, increasing preclinical and clinical trials, and proof of concept studies. To this end, iCRIN is building and monitoring cohorts of patients suffering from neurodegenerative diseases, whose clinical, biological and neuroimaging data will be organized into databases.

Parkinson's disease and movement disorders

Parkinson's disease and movement disorders

The iCRIN dedicated to Parkinson’s disease and movement disorders benefits from the synergies between the team of Olga Corti and Jean-Christophe Corvol and that of Marie Vidailhet and Stéphane Lehéricy. Its two main objectives are to identify biomarkers of disease severity, disease progression and treatment response, and to decipher pathophysiologic mechanisms underlying behavioural and motor control disorders in rare movement disorders.

Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

The SLA centre in Paris is one of the most important in Europe, both in terms of new patients and patients monitored. He collaborates with several members of the team of Séverine Boillée at Paris Brain Institute. The iCRIN SLA is composed of four axes: to elucidate the triggering of Amyotrophic Lateral Sclerosis (ALS or Charcot’s disease) and to identify biomarkers; to understand the phenomenon of propagation of motoneuron dysfunction; to discover why mechanisms of innervation compensation are maintained in certain patients; to study the effect of the opening of the blood-brain barrier by focusing ultrasound in ALS.

Neurological Intensive Care

Neurological Intensive Care

The Neurological Intensive Care Unit is a highly experienced facility for the acute management of patients with peripheral and/or central nervous system disorders. His activity focuses on four main pathologies: the categorization and monitoring of disorders of consciousness in collaboration with the team of Lionel Naccache; the diagnosis and therapeutics of states of epilepsy with the team of Stéphane Charpier and Vincent Navarro; the early diagnosis of encephalitis; the creation of a large clinical database in myasthenia.

Neurosurgery

Neurosurgery

Virtually all of the clinical activities of the neurosurgery department have research programs with Paris Brain Institute teams and platforms. The iCRIN aims to ensure the development of multi-modal databases of future clinical trials. Five main lines of research: identification of factors predictive of morbidity and mortality in cohorts of patients with brain tumours and aneurysms; new targets for deep brain stimulation and brain-brain interfaces; opening of the blood-brain barrier in various neurological pathologies; new therapeutic approaches for meningitis; ex vivo human tissue for cellular electrophysiology.

Neurogenetics

Neurogenetics

The clinical research centre NEUROLOP, including the actors of the Rare Diseases Reference Centres of the Department of Genetics of the Hospital and Paris Brain Institute, aims to decipher the phenotypes associated with genes involved in neurogenetic pathologies such as spinocerebral ataxia or Huntington’s disease, from birth to adulthood; the search for clinical, imaging, biological and genetic biomarkers; innovative therapeutic trials in The transition from neurodevelopmental defects to programmed neuron loss in adulthood in neurogenetic diseases related to basic research.

Neuro-oncology

Neuro-oncology

The association of the Department of Neuro-Oncology with a dedicated research team, led by Marc Sanson and Emmanuelle Huillard at Paris Brain Institute, a unique tumour bank (Onconeurotek), a pre-clinical therapeutic research group (GlioTex, led by Ahmed Idbaih) and a certification from the National Cancer Institute for early phase clinical trials and advanced therapies make it possible to achieve the following objectives: In this context, the Commission will continue to support the development of the European Research Area (ERA) and the European Research Area (ERA).

Stroke

Stroke

The objectives of the stroke iCRIN are: participation/coordination of randomised controlled trials, use of Big Data to construct a dynamic prognostic model of the outcome of a cerebral vascular accident (stroke); identification of new structural and functional markers of the consequences of stroke; development of innovative therapeutic approaches in rehabilitation, such as non-invasive brain stimulation techniques, playful and innovative rehabilitation strategies. (serious games, neurofeedback) or pharmacological treatments.

Orthopaedic surgery

Orthopaedic surgery

The clinical project of the Pitié-Salpêtrière department of orthopaedics focuses on three main themes: the genetic etiology of idiopathic scoliosis, in collaboration with Claire Wyart’s team at Paris Brain Institute; the establishment of a systematic registry of neurological status before and after the operation for all patients in the spinal unit; the development of various prospective analysis protocols linking neurosciences with sports surgeries or surgeries; and the development of a system for the diagnosis of idiopathic scoliosis. spinal cord injuries.

Adult Psychiatry

Adult Psychiatry

The iCRIN Psychiatry offers a multi-modal approach combining brain stimulation with pharmacotherapy or psychotherapy. It represents a strong interface between clinical services and Paris Brain Institute, particularly with the team of Philippe Fossati and Liane Schmidt. Two lines of research are currently being explored: the development of pragmatic trials in stress dysregulation disorders, such as post-traumatic stress disorder; the exploration of neuromodulation of psychiatric networks; and drug use disorders.

Head injuries

Head injuries

New approaches to integrating multi-modal data are critical for tracking brain vulnerability, individual trajectories, and the progression of head injuries (CBT). This iCRIN aims to structure and develop a large prospective cohort of head trauma patients explored in a multimodal way (clinical, radiology, physiology), and to develop the modelling of the results, including using statistical learning techniques.

Multiple sclerosis

Multiple sclerosis

In the rapidly evolving field of sleep physiology and medicine, this iCRIN focuses on better describing the semiology of these disorders, their genetics, and neurophysiological and brain imaging markers and their optimal treatment. It also aims to understand the mechanisms of normal sleep and dreaming; to determine whether certain brain functions (for example, memory or emotions) are related to REM sleep or not; to study preclinical neurodegeneration and to try neuroprotective treatments in patients with Parkinson’s disease and Lewy body dementia.

News that might interest you

Interneurones. Crédit : UCLA Broad Stem Cell Research Center.
Stimulating specific neurons in the striatum stops compulsive behaviour
What if we could resist compulsions? These irrational behaviours, particularly common in obsessive-compulsive disorder (OCD), are hard to suppress. At Paris Brain Institute, Éric Burguière's team shows that we can anticipate them and block them ...
09.10.2024 Research, science & health
Les nerfs moteurs présents dans la moelle épinière se projettent vers la périphérie, où ils entrent en contact avec les muscles, formant des connexions appelées jonctions neuromusculaires. Crédit : James N. Sleigh.
Ultrasound show unexpected effects on motor neuron disease
Over the past fifteen years, neurosurgeons have been perfecting a fascinating technique: using ultrasound to temporarily open the blood-brain barrier to facilitate the action of therapeutic molecules in the central nervous system. At Paris Brain ...
09.05.2024 Research, science & health
Un neurone
Rett syndrome: a new gene therapy on the way
Gene therapy could be our best chance of treating Rett syndrome, a neurological disorder that causes severe intellectual and motor impairments. At Paris Brain Institute, Françoise Piguet and her colleagues have looked closely at brain cholesterol ...
07.16.2024 Research, science & health
Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and ...
06.28.2024 Research, science & health
Une tête de statue de l'île de Pâques sur laquelle sont posées des éléctrodes
A multimodal approach to better predict recovery in patients with disorders of consciousness
When a patient is admitted to intensive care due to a disorder of consciousness—such as a coma—establishing their neurological prognosis is a crucial yet challenging task. To reduce the uncertainty that precedes the medical decision, a group of ...
05.30.2024 Research, science & health
Population de bactéries commensales (en rouge) dans un intestin grêle de souris. Crédit : University of Chicago
The composition of the gut microbiota could influence decision-making
The way we make decisions in a social context can be explained by psychological, social, and political factors. But what if other forces were at work? Hilke Plassmann and her colleagues from the Paris Brain Institute and the University of Bonn show ...
05.16.2024 Research, science & health
See all our news